Medical Management of Uterine Fibroids
The medical management of uterine fibroids is an evolving practice. As novel therapies are introduced, clinical practice guidance has been updated to provide evidence-based recommendations on the evolving role of these agents in clinical practice. This online course reviews the role of medical therapy in the management of uterine fibroids. The Society of Obstetricians and Gynaecologists of Canada (SOGC) provides guidance for The Management of Uterine Leiomyomas (SOGC CPG #318). Additional SOGC guidance of relevance to this topic includes: Abnormal Uterine Bleeding in Pre-Menopausal Women, and The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility. “Until recently, medical management options for uterine leiomyomas have been of limited value because of their moderate efficacy and/or associated adverse effects. Novel therapies at the receptor and gene levels have emerged or are undergoing investigation and may eventually offer better long-term management options.” (SOGC Clinical Practice Guideline #318)
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Society of Obstetricians and Gynaecologists of Canada. You may claim a maximum of 3.0 hours for this course (credits are automatically calculated).
Once you have registered, you can access the course by going to your profile and clicking on "Go to SOGC Online Platform".
Please login to register.